Pacifico National recalls
Pacifico National has 5 recalls on record with the FDA and USDA, the earliest in 2016 and the latest reported on 18 Sep 2019. The most frequent reason is sterility.
Total recalls5since 2016
Last 12 months0reported
Class I240% of total
Ongoing0latest 18 Sep 2019
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 2 40%Class II 3 60%Class III 0 0%
Why pacifico national is recalled
Product types
By year
All pacifico national recalls, newest first
5 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Bevacizumab, 25 mg/ MJ Syringe Intravitreal Injection recalled | Pacifico National | Sterility | PR |
| Drug | CLASS II | Bevacizumab, 5 mg/, Norm-Ject Syringe Intravitreal recalled | Pacifico National | Sterility | PR |
| Drug | CLASS II | Bevacizumab 25 mg/ MJ syringe Intravitreal Injection recalled | Pacifico National | Packaging Defects | Nationwide |
| Drug | CLASS I | Avastin (Bevacizumab) 25 mg/ syringe recalled by Pacifico National | Pacifico National | Sterility | Nationwide |
| Drug | CLASS I | Avastin (Bevacizumab) 2 mg/ syringe recalled by Pacifico National | Pacifico National | Sterility | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.